Announcement • Jun 30
Shanghai Huayi Group Corporation Limited to Report First Half, 2026 Results on Aug 25, 2026 Shanghai Huayi Group Corporation Limited announced that they will report first half, 2026 results on Aug 25, 2026 Announcement • Jun 05
Shanghai Huayi Group Corporation Limited, Annual General Meeting, Jun 29, 2026 Shanghai Huayi Group Corporation Limited, Annual General Meeting, Jun 29, 2026, at 14:00 China Standard Time. New Risk • May 06
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 91% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.2% net profit margin). Major Estimate Revision • Apr 27
Consensus revenue estimates increase by 13%, EPS downgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast increased from CN¥45.2b to CN¥51.1b. EPS estimate fell from CN¥0.65 to CN¥0.52. Net income forecast to grow 98% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥10.92. Share price was steady at CN¥9.83 over the past week. Reported Earnings • Apr 22
Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2025 results: EPS: CN¥0.26 (down from CN¥0.43 in FY 2024). Revenue: CN¥46.4b (up 4.0% from FY 2024). Net income: CN¥554.7m (down 39% from FY 2024). Profit margin: 1.2% (down from 2.0% in FY 2024). Revenue exceeded analyst estimates by 6.0%. Earnings per share (EPS) missed analyst estimates by 52%. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Announcement • Mar 30
Shanghai Huayi Group Corporation Limited to Report Q1, 2026 Results on Apr 28, 2026 Shanghai Huayi Group Corporation Limited announced that they will report Q1, 2026 results on Apr 28, 2026 Announcement • Mar 23
Shanghai Huayi Group Corporation Limited(SHSE:900909) dropped from FTSE All-World Index (USD) Shanghai Huayi Group Corporation Limited(SHSE:900909) dropped from FTSE All-World Index (USD) Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥11.42, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥9.34, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 53% over the past three years. Announcement • Dec 26
Shanghai Huayi Group Corporation Limited to Report Fiscal Year 2025 Results on Apr 21, 2026 Shanghai Huayi Group Corporation Limited announced that they will report fiscal year 2025 results on Apr 21, 2026 Reported Earnings • Oct 24
Third quarter 2025 earnings released: CN¥0.046 loss per share (vs CN¥0.091 profit in 3Q 2024) Third quarter 2025 results: CN¥0.046 loss per share (down from CN¥0.091 profit in 3Q 2024). Revenue: CN¥11.7b (down 9.7% from 3Q 2024). Net loss: CN¥92.8m (down 145% from profit in 3Q 2024). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Announcement • Sep 30
Shanghai Huayi Group Corporation Limited to Report Q3, 2025 Results on Oct 22, 2025 Shanghai Huayi Group Corporation Limited announced that they will report Q3, 2025 results on Oct 22, 2025 Reported Earnings • Aug 26
Second quarter 2025 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.16 (up from CN¥0.13 in 2Q 2024). Revenue: CN¥13.8b (up 17% from 2Q 2024). Net income: CN¥345.5m (up 32% from 2Q 2024). Profit margin: 2.5% (up from 2.2% in 2Q 2024). Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Announcement • Jun 30
Shanghai Huayi Group Corporation Limited to Report First Half, 2025 Results on Aug 26, 2025 Shanghai Huayi Group Corporation Limited announced that they will report first half, 2025 results on Aug 26, 2025 New Risk • May 09
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 32% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.0% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Announcement • May 06
Shanghai Huayi Group Corporation Limited, Annual General Meeting, May 30, 2025 Shanghai Huayi Group Corporation Limited, Annual General Meeting, May 30, 2025, at 09:00 China Standard Time. Location: 3F, No. 560, Xujiahui Road, Shanghai China Reported Earnings • Apr 24
Full year 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.42 in FY 2023) Full year 2024 results: EPS: CN¥0.43 (up from CN¥0.42 in FY 2023). Revenue: CN¥45.1b (up 10% from FY 2023). Net income: CN¥910.6m (flat on FY 2023). Profit margin: 2.0% (down from 2.2% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Mar 28
Shanghai Huayi Group Corporation Limited to Report Q1, 2025 Results on Apr 29, 2025 Shanghai Huayi Group Corporation Limited announced that they will report Q1, 2025 results on Apr 29, 2025 Announcement • Dec 27
Shanghai Huayi Group Corporation Limited to Report Fiscal Year 2024 Results on Apr 22, 2025 Shanghai Huayi Group Corporation Limited announced that they will report fiscal year 2024 results on Apr 22, 2025 Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.26 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.26 in 3Q 2023). Revenue: CN¥12.0b (up 2.3% from 3Q 2023). Net income: CN¥189.4m (down 66% from 3Q 2023). Profit margin: 1.6% (down from 4.7% in 3Q 2023). Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Shanghai Huayi Group Corporation Limited to Report Q3, 2024 Results on Oct 29, 2024 Shanghai Huayi Group Corporation Limited announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥6.59, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 38% over the past three years. Announcement • Jun 28
Shanghai Huayi Group Corporation Limited to Report First Half, 2024 Results on Aug 27, 2024 Shanghai Huayi Group Corporation Limited announced that they will report first half, 2024 results on Aug 27, 2024 Announcement • Mar 30
Shanghai Huayi Group Corporation Limited to Report Q1, 2024 Results on Apr 30, 2024 Shanghai Huayi Group Corporation Limited announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥5.24, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years. Announcement • Dec 29
Shanghai Huayi Group Corporation Limited to Report Fiscal Year 2023 Results on Apr 30, 2024 Shanghai Huayi Group Corporation Limited announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.043 (vs CN¥0.16 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.043 (down from CN¥0.16 in 2Q 2022). Revenue: CN¥10.2b (up 2.5% from 2Q 2022). Net income: CN¥100.4m (down 72% from 2Q 2022). Profit margin: 1.0% (down from 3.6% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • Jun 28
Shanghai Huayi Group Corporation Limited to Report First Half, 2023 Results on Aug 29, 2023 Shanghai Huayi Group Corporation Limited announced that they will report first half, 2023 results on Aug 29, 2023 Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Yuan Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.46 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.05 (down from CN¥0.46 in 3Q 2021). Revenue: CN¥10.2b (down 14% from 3Q 2021). Net income: CN¥107.6m (down 89% from 3Q 2021). Profit margin: 1.1% (down from 8.1% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.43 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.16 (down from CN¥0.43 in 2Q 2021). Revenue: CN¥10.1b (down 11% from 2Q 2021). Net income: CN¥358.7m (down 62% from 2Q 2021). Profit margin: 3.5% (down from 8.2% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 5.4%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥8.87, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years. Reported Earnings • Apr 28
First quarter 2022 earnings: EPS exceeds analyst expectations First quarter 2022 results: EPS: CN¥0.32 (up from CN¥0.29 in 1Q 2021). Revenue: CN¥9.67b (up 12% from 1Q 2021). Net income: CN¥671.4m (up 10% from 1Q 2021). Profit margin: 6.9% (down from 7.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.5%. Over the next year, revenue is forecast to stay flat compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. 1 highly experienced director. Independent Director Yimin Zhang was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Mar 10
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: CN¥1.39 (up from CN¥0.20 in FY 2020). Revenue: CN¥38.7b (up 38% from FY 2020). Net income: CN¥2.96b (up CN¥2.54b from FY 2020). Profit margin: 7.7% (up from 1.5% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) exceeded analyst estimates by 1.5%. Over the next year, revenue is forecast to grow 4.6%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.46 (vs CN¥0.066 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥12.1b (up 67% from 3Q 2020). Net income: CN¥954.4m (up CN¥815.5m from 3Q 2020). Profit margin: 7.9% (up from 1.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year and the company’s share price has also increased by 3% per year. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 24% share price decline to CN¥11.49, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 34% over the past three years. Valuation Update With 7 Day Price Move • Sep 15
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥15.41, the stock trades at a trailing P/E ratio of 15.9x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 92% over the past three years. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.045 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥11.6b (up 68% from 2Q 2020). Net income: CN¥937.5m (up CN¥825.7m from 2Q 2020). Profit margin: 8.1% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥9.80, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years. Reported Earnings • Apr 28
Full year 2020 earnings released: EPS CN¥0.20 (vs CN¥0.30 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥28.4b (down 24% from FY 2019). Net income: CN¥423.4m (down 32% from FY 2019). Profit margin: 1.5% (down from 1.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 08
New 90-day high: CN¥6.66 The company is up 16% from its price of CN¥5.73 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Announcement • Jan 28
Shanghai Huayi Group Corporation Limited(XSSC:600623) dropped from S&P Global BMI Index Shanghai Huayi Group Corporation Limited(XSSC:600623) dropped from S&P Global BMI Index Is New 90 Day High Low • Dec 07
New 90-day high: CN¥6.60 The company is up 16% from its price of CN¥5.69 on 08 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥134.6m, down 83% from the prior year. Total revenue was CN¥26.5b over the last 12 months, down 37% from the prior year. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥5.42 The company is down 7.0% from its price of CN¥5.83 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Announcement • Oct 27
Shanghai Huayi Group Corporation Limited to Report Q3, 2020 Results on Oct 30, 2020 Shanghai Huayi Group Corporation Limited announced that they will report Q3, 2020 results on Oct 30, 2020 Announcement • Jul 09
Shanghai Huayi Group Corporation Limited to Report First Half, 2020 Results on Aug 25, 2020 Shanghai Huayi Group Corporation Limited announced that they will report first half, 2020 results on Aug 25, 2020